Narayana Hrudayalaya posts consolidated operating income at Rs 4,520 m in Q1FY17

Consolidated EBITDA stood at Rs 550 million

Narayana Hrudayalaya has posted its financial results for the first quarter (Q1FY17) ended June 30, 2016. The consolidated total operating income was Rs 4,520 million for Q1FY17 as compared to Rs 3,787 million in the corresponding period of the previous year reflecting an increase of 19 per cent. Consolidated EBITDA stood at Rs 550 million as compared to Rs 367 million during the corresponding period of previous year reflecting an increase of 50 per cent. The consolidated EBITDA margin was at 12.2% for Q1FY17 as against 9.7 per cent in Q1FY16, improved by 247 bps

Profit after tax (PAT) after minority interest and share in associate stood at Rs 167 million for Q1FY17 as compared to a loss of Rs 5 million in the corresponding period of the previous year.

As per previously applicable Generally Accepted Accounting Principles (‘Previous GAAP’), consolidated EBITDA for the quarter was Rs 555 million (y-o-y of 39 per cent) and consolidated PAT after minority interest and share in associate was Rs 171 million (y-o-y of 989 per cent).

As on June 30, 2016, the consolidated net debt was Rs 1,742 million representing a net debt to equity ratio of 0.20.

Dr Ashutosh Raghuvanshi, Vice Chairman, Managing Director and Group CEO, Narayana Hrudayalaya said, “Our quarter performance in Q1FY17 has been in line with the stated objectives. The key highlight of the quarter has been the commissioning of our 230-bed super speciality hospital at Kakriyal, Jammu. The response has been really encouraging and we are seeing good traction in our operations at this facility. This apart, enhanced operating efficiencies in line with maturity of facilities are playing a very significant part in sustaining the earnings for the forthcoming future. Besides, performance of our hospital at Cayman Islands has picked up well with the unit expanding its service offerings through the programmes of plastic surgery, interventional radiology and interventional neurology. Overall, the business looks bright and we are confident of growing upon the strong momentum as we move forward.”

EH News Bureau